CytomX Therapeutics, Inc.

CTMXNASDAQHealthcare● Active

$2.93

$-0.07(-2.18%)

Market Cap$471936646

P/E Ratio—

52W High$8.21

52W Low$1.72

Avg Volume6.9M

Open$3.05

Beta2.09

Employees Ownership Insider Trades

CytomX Therapeutics, Inc. (CTMX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · CTMX · as of Mar 16, 2026

Latest filing snapshot

-50-42.02%vs prior year

CytomX Therapeutics, Inc. (CTMX) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

Change (1Y)

-50

Growth % (1Y)

-42.02%

Revenue / Employee

$1.10M

Net Income / Employee

$-251.7K

Market Cap

$472M

CTMX Employee Count

2015 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-16	2025-12-31	69	-50	-42.02%
2025-03-06	2024-12-31	119	-1	-0.83%
2024-03-11	2023-12-31	120	+4	+3.45%
2023-03-27	2022-12-31	116	-58	-33.33%
2022-03-01	2021-12-31	174	+30	+20.83%
2021-02-24	2020-12-31	144	-14	-8.86%
2020-02-27	2019-12-31	158	+21	+15.33%
2019-02-27	2018-12-31	137	+45	+48.91%
2018-03-07	2017-12-31	92	+14	+17.95%
2017-03-02	2016-12-31	78	+13	+20.00%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

IOVA

Iovance Biotherapeutics, Inc.

838$1.5B #2

DNA

Ginkgo Bioworks Holdings, Inc.

Astria Therapeutics, Inc.

78$718M #5

CTMX

CytomX Therapeutics, Inc.YOU

69$472M #6

AVBP

ArriVent BioPharma, Inc. Common Stock

52$1.4B #7

AVXL

Anavex Life Sciences Corp.

42$239M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · CTMX peer comparison

About CTMX employees

CTMX Employees · Headcount

CytomX Therapeutics, Inc. (CTMX) employee data is sourced from the annual SEC 10-K filing. As of 2025, CytomX Therapeutics, Inc. had 69 full-time employees globally. Full-time employees only. Global consolidated headcount.

CytomX Therapeutics, Inc. employs 69 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $1.10M, reflecting the company's operational efficiency.

CytomX Therapeutics, Inc.'s workforce decreased by 50 (42.02%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

CytomX Therapeutics, Inc.'s revenue per employee of $1.10M positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

CTMX Employees · 5 questions

As of the latest SEC 10-K filing (2025), CytomX Therapeutics, Inc. had 69 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

CytomX Therapeutics, Inc. employee counthow many employees does CytomX Therapeutics, Inc. haveCTMX total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-16